170 related articles for article (PubMed ID: 8101355)
1. Design, synthesis and biological activity of protaxols.
Nicolaou KC; Riemer C; Kerr MA; Rideout D; Wrasidlo W
Nature; 1993 Jul; 364(6436):464-6. PubMed ID: 8101355
[TBL] [Abstract][Full Text] [Related]
2. Taxol: a history of pharmaceutical development and current pharmaceutical concerns.
Adams JD; Flora KP; Goldspiel BR; Wilson JW; Arbuck SG; Finley R
J Natl Cancer Inst Monogr; 1993; (15):141-7. PubMed ID: 7912520
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of 2-acyl analogues of paclitaxel (Taxol).
Kingston DG; Chaudhary AG; Chordia MD; Gharpure M; Gunatilaka AA; Higgs PI; Rimoldi JM; Samala L; Jagtap PG; Giannakakou P; Jiang YQ; Lin CM; Hamel E; Long BH; Fairchild CR; Johnston KA
J Med Chem; 1998 Sep; 41(19):3715-26. PubMed ID: 9733497
[TBL] [Abstract][Full Text] [Related]
4. [Synthesis and structure-activity relationships of novel 14 beta-side chain taxol derivatives].
Liu R; Yin D; Wang D; Li C; Guo J; Liang X
Yao Xue Xue Bao; 1998 Dec; 33(12):910-8. PubMed ID: 12016856
[TBL] [Abstract][Full Text] [Related]
5. Total synthesis of taxol.
Nicolaou KC; Yang Z; Liu JJ; Ueno H; Nantermet PG; Guy RK; Claiborne CF; Renaud J; Couladouros EA; Paulvannan K
Nature; 1994 Feb; 367(6464):630-4. PubMed ID: 7906395
[TBL] [Abstract][Full Text] [Related]
6. Relationship between the structure of taxol and other taxanes on induction of tumor necrosis factor-alpha gene expression and cytotoxicity.
Burkhart CA; Berman JW; Swindell CS; Horwitz SB
Cancer Res; 1994 Nov; 54(22):5779-82. PubMed ID: 7954398
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity study on the actions of taxol and related taxanes on primary cultures of adrenal medullary cells.
McKay DB
J Pharmacol Exp Ther; 1989 Mar; 248(3):1302-7. PubMed ID: 2564892
[TBL] [Abstract][Full Text] [Related]
8. O-N intramolecular acyl migration reaction in the development of prodrugs and the synthesis of difficult sequence-containing bioactive peptides.
Sohma Y; Hayashi Y; Skwarczynski M; Hamada Y; Sasaki M; Kimura T; Kiso Y
Biopolymers; 2004; 76(4):344-56. PubMed ID: 15386265
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and bioactivities of steroid-linked taxol analogues as potential targeted drugs for prostate and breast cancer.
Liu C; Strobl JS; Bane S; Schilling JK; McCracken M; Chatterjee SK; Rahim-Bata R; Kingston DG
J Nat Prod; 2004 Feb; 67(2):152-9. PubMed ID: 14987051
[TBL] [Abstract][Full Text] [Related]
10. Butitaxel analogues: synthesis and structure-activity relationships.
Ali SM; Hoemann MZ; Aubé J; Georg GI; Mitscher LA; Jayasinghe LR
J Med Chem; 1997 Jan; 40(2):236-41. PubMed ID: 9003522
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of self-immolative glucuronide-based prodrugs of a phenol mustard.
Lougerstay-Madec R; Florent JC; Monneret C; Nemati F; Poupon MF
Anticancer Drug Des; 1998 Dec; 13(8):995-1007. PubMed ID: 10335272
[TBL] [Abstract][Full Text] [Related]
12. Sulfonyl-containing aldophosphamide analogues as novel anticancer prodrugs targeted against cyclophosphamide-resistant tumor cell lines.
Jain M; Fan J; Baturay NZ; Kwon CH
J Med Chem; 2004 Jul; 47(15):3843-52. PubMed ID: 15239662
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
Safavy A; Bonner JA; Waksal HW; Buchsbaum DJ; Gillespie GY; Khazaeli MB; Arani R; Chen DT; Carpenter M; Raisch KP
Bioconjug Chem; 2003; 14(2):302-10. PubMed ID: 12643740
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of brefeldin A sulfide derivatives as prodrug candidates with enhanced aqueous solubilities.
Argade AB; Devraj R; Vroman JA; Haugwitz RD; Hollingshead M; Cushman M
J Med Chem; 1998 Aug; 41(18):3337-46. PubMed ID: 9719586
[TBL] [Abstract][Full Text] [Related]
15. Low potency of taxol at microtubule minus ends: implications for its antimitotic and therapeutic mechanism.
Derry WB; Wilson L; Jordan MA
Cancer Res; 1998 Mar; 58(6):1177-84. PubMed ID: 9515803
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity profiles of eleutherobin analogs and their cross-resistance in Taxol-resistant cell lines.
McDaid HM; Bhattacharya SK; Chen XT; He L; Shen HJ; Gutteridge CE; Horwitz SB; Danishefsky SJ
Cancer Chemother Pharmacol; 1999; 44(2):131-7. PubMed ID: 10412947
[TBL] [Abstract][Full Text] [Related]
17. Taxol is converted to 7-epitaxol, a biologically active isomer, in cell culture medium.
Ringel I; Horwitz SB
J Pharmacol Exp Ther; 1987 Aug; 242(2):692-8. PubMed ID: 2886648
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of a water-soluble taxol analogue: taxol-sialyl conjugate.
Takahashi T; Tsukamoto H; Yamada H
Bioorg Med Chem Lett; 1998 Jan; 8(1):113-6. PubMed ID: 9925441
[TBL] [Abstract][Full Text] [Related]
19. Fluorescent taxoids.
Guy R; Scott Z; Sloboda R; Nicolaou K
Chem Biol; 1996 Dec; 3(12):1021-31. PubMed ID: 9000007
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of taxoids with improved cytotoxicity and solubility for use in tumor-specific delivery.
Miller ML; Roller EE; Zhao RY; Leece BA; Ab O; Baloglu E; Goldmacher VS; Chari RV
J Med Chem; 2004 Sep; 47(20):4802-5. PubMed ID: 15369381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
